Synthesis 2009(19): 3179-3210  
DOI: 10.1055/s-0029-1216976
REVIEW
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of Glycosyltransferase Inhibitors

Tetsuya Kajimoto*a, Manabu Nodeb
a Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan
Fax: +81(72)6901084; e-Mail: kajimoto@gly.oups.ac.jp; e-Mail: kajimoto@mb.kyoto-phu.ac.jp;
b Kyoto Pharmaceutical University, 1 Shichono-cho, Misasagi, Yamashina-ku, Kyoto 607-8412, Japan
Weitere Informationen

Publikationsverlauf

Received 12 May 2009
Publikationsdatum:
03. September 2009 (online)

Abstract

Glycosyltransferases and glycosidases work together to construct the oligosaccharide moieties of biologically active glycoconjugates. Although many excellent glycosidase inhibitors have been developed, some of which are in clinical use, there are relatively few promising candidates of glycosyltransferase inhibitors. In this review, we summarize the current state of the development of glycosyltransferase inhibitors.

1 Introduction

2 Basic Strategy for Designing Glycosyltransferase Inhibitors

3 Sugar Nucleotide Analogues

4 Analogues of Acceptor Oligosaccharides (Acceptor
Analogues)

5 Bisubstrate Inhibitors

6 High-Throughput Screening: Discovering Structurally
Simple Inhibitors

7 Antisense Inhibitors

8 Questions and Future Directions